$21.36
0.00% today
Nasdaq, Dec 04, 04:47 pm CET
ISIN
US05337M1045
Symbol
AVDL

Avadel Pharmaceuticals PLC Sponsored ADR Stock price

$21.36
+2.44 12.90% 1M
+11.93 126.51% 6M
+10.85 103.24% YTD
+11.42 114.89% 1Y
+12.61 144.11% 3Y
+14.36 205.14% 5Y
+6.74 46.10% 10Y
+2.33 12.24% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+0.01 0.05%
ISIN
US05337M1045
Symbol
AVDL
Industry

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$2.0b
Net debt
positive
Cash
$91.6m
Shares outstanding
97.2m
Valuation (TTM | estimate)
P/E
negative | 93.6
P/S
8.4 | 7.5
EV/Sales
8.2 | 7.3
EV/FCF
105.0
P/B
21.3
Financial Health
Equity Ratio
45.0%
Return on Equity
-66.1%
ROCE
-3.6%
ROIC
-0.5%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$248.5m | $277.7m
EBITDA
$-1.3m | $34.6m
EBIT
$-5.0m | $27.5m
Net Income
$-280.0k | $22.2m
Free Cash Flow
$19.4m
Growth (TTM | estimate)
Revenue
79.9% | 64.2%
EBITDA
97.9% | 187.1%
EBIT
92.2% | 164.8%
Net Income
99.6% | 145.4%
Free Cash Flow
123.4%
Margin (TTM | estimate)
Gross
91.1%
EBITDA
-0.5% | 12.5%
EBIT
-2.0%
Net
-0.1% | 8.0%
Free Cash Flow
7.8%
More
EPS
$0.0
FCF per Share
$0.2
Short interest
8.0%
Employees
188
Rev per Employee
$900.0k
Show more

Is Avadel Pharmaceuticals PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Avadel Pharmaceuticals PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

6x Buy
38%
10x Hold
63%

Analyst Opinions

16 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

Buy
38%
Hold
63%

Financial data from Avadel Pharmaceuticals PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
249 249
80% 80%
100%
- Direct Costs 22 22
98% 98%
9%
226 226
78% 78%
91%
- Selling and Administrative Expenses 191 191
8% 8%
77%
- Research and Development Expense 40 40
200% 200%
16%
-1.30 -1.30
98% 98%
-1%
- Depreciation and Amortization 3.68 3.68
84% 84%
1%
EBIT (Operating Income) EBIT -4.98 -4.98
92% 92%
-2%
Net Profit -0.28 -0.28
100% 100%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Avadel Pharmaceuticals PLC Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avadel Pharmaceuticals PLC Sponsored ADR Stock News

Neutral
GlobeNewsWire
about 19 hours ago
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Neutral
GlobeNewsWire
3 days ago
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT MADE UNDER RULE 17(A) (AS AMENDED BY SECTION 3 OF APPENDIX 4) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”) FOR IMMEDIATE RELEASE...
Positive
Reuters
15 days ago
Alkermes said on Wednesday it has sweetened its offer to buy Avadel Pharmaceuticals , beating a rival bid from Denmark's Lundbeck and valuing the sleep disorder drugmaker at up to $2.37 billion.
More Avadel Pharmaceuticals PLC Sponsored ADR News

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Gregory Divis
Employees 188
Founded 2015
Website www.avadel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today